MedTrace Logo

Forearm Immobilization, Metabolic Health, and Muscle Loss

NCT03866512 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2024-06-21

Study results available
· View outcomes & findings →

Summary

The present study will investigate the impact of altered substrate availability on muscle atrophy, insulin sensitivity and muscle protein synthesis following short-term forearm immobilization

Conditions

  • Healthy

Interventions

BEHAVIORAL

Forearm immobilization

Two days of forearm immobilization

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • University of Exeter

    lead OTHER

Principal Investigators

  • Marlou Dirks, PhD · University of Exeter

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-05-10
Primary Completion
2021-07-01
Completion
2021-07-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03866512 on ClinicalTrials.gov